Prevalence and Predictors of Distal Limb Ischemia in Minimally Invasive Cardiac Surgery.

Peripheral arterial cannulation is a necessity for installation of cardiopulmonary bypass in minimally invasive cardiac surgery (MICS). In the vast majority of cases, the femoral artery is the preferred arterial cannulation site. Distal limb hypoperfusion and ischemia can occur in the cannulated limb since antegrade perfusion is not routinely provided. Furthermore, the diameter of the cannula required to maintain adequate cardiopulmonary bypass (CPB) flow is often approaching that of the patient's femoral artery diameter, compromising distal blood flow. The possibility of distal limb ischemia is often raised as a criticism to peripheral cannulation for cardiopulmonary bypass and by extent to minimally invasive cardiac surgery. Ischemia of the lower limb is of high incidence in patients undergoing extracorporeal membrane oxygenation (ECMO) therapy, in which the same femoral cannulation technique is used. Therefore this complication has extensively been described in ECMO literature. However, no clinical trials have been performed in patients undergoing MICS, despite the same cannulation and perfusion route. ECMO patients often differ from MICS patients in morbidity as well as in duration of cannulation. Up to now, one could not observe any clinical sequelae of limb ischemia in MICS patients but a formal study of distal leg perfusion in MICS is recommended to screen its safety and to identify possible risk factors.

Study Overview

• Status: Completed
• Conditions: Perfusion; Complications
• Intervention / Treatment: Other: Distal leg perfusion

Detailed Description

Study design and setting Single-center prospective observational cohort study in patients undergoing minimally invasive cardiac surgery with peripheral arterial cannulation. This is the standard of care in the institution of the investigators.

Population All consecutive patients presenting for minimally invasive cardiac surgery will be screened for participation to the study. Eligible participants fulfill all inclusion criteria and no exclusion criteria (described below in more detail).

NIRS Near infrared spectroscopy (NIRS) is currently accepted as the golden standard monitoring tool for tissue oxygenation and for early detection of ischemia. The NIRS measures and displays a percent regional oxygenation saturation (rSO2). This value quantifies the percentage of regional hemoglobin oxygen saturation. It is measured by an electrode placed on the skin, and is therefore totally non-invasive. NIRS originally has been used to measure brain saturation, but its indications have been extended to any region of interest. Multiple studies validated NIRS as a useful monitor for detection of ischemia of the lower extremities in various settings (ECMO patients, patients with peripherally vascular disease). Patton-Rivera at al. showed rSO2 differentials > 15% had a 100% sensitivity and specificity for the detection of clinically markable hypoperfusion of the cannulated leg in ECMO patients.

Data collection Patient demographics and medical history will be collected together with the EuroScore II i.e the estimated risk of in-hospital death after cardiac surgery. NIRS values will be coded and anonymously recorded onto a Universal Serial Bus (USB) device and saved on a pc with limited access. rSO2 differentials between the cannulated and non-cannulated leg and Tissue Oxygenation Index (TOI) differentials from baseline in the cannulated leg will be noted (%). After completion and publication of the study all data will be deleted from the device.

Data for analyses of variables will be extracted from the anesthetic and perfusion charts. These charts are stored in the patients individual record.

Interventions On arrival in the operating room, oximeter pads of a NIRO-200NX (NIRO,Hamamatsu® , Japan) NIRS monitor will be placed on the muscles of the calf bilaterally. Lower extremity NIRS is an added monitoring tool as it is currently not being used in our institutional clinical management. Neither anesthetic nor surgical plans will be altered by the study and are left to the discretion of the attending consultant. Also, perfusion goals may not be altered to the results of the leg NIRS. Therefore, the NIRS display will be covered in the operating room throughout the surgery.

• Study Type: Observational
• Enrollment (Actual): 280

Contacts and Locations

Study Locations

• Belgium
  • Hasselt, Belgium
    • Department of Anesthesiology and Intensive Care

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

All consecutive patients presenting for minimally invasive cardiac surgery will be screened for participation to the study. Eligible participants fulfill all inclusion criteria and no exclusion criteria.

Description

Inclusion Criteria:

1. Patients undergoing minimally invasive cardiac surgery older than 18 years.

Exclusion Criteria:

1. History of leg amputation.
2. Calf muscle atrophy due to neuromuscular disorder or muscle diseases.
3. Stanford type A aortic dissection.
4. BMI > 40.
5. Allergy for NIRS electrode.
6. Revision surgery < 72h after primary surgery.
7. Postoperative need for intra-aortic balloon pump and/or ECMO.

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Minimally invasive cardiac surgery; All consecutive patients presenting for minimally invasive cardiac surgery will be screened for participation to the study.

Other: Distal leg perfusion; On arrival in the operating room, oximeter pads of a NIRO-200NX (NIRO,Hamamatsu® , Japan) NIRS monitor will be placed on the muscles of the calf bilaterally. Lower extremity NIRS is an added monitoring tool as it is currently not being used in our institutional clinical management. Neither anesthetic nor surgical plans will be altered by the study and are left to the discretion of the attending consultant. Also, perfusion goals may not be altered to the results of the leg NIRS. Therefore, the NIRS display will be covered in the operating room throughout the surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Drop of 15% in regional oxygen saturation (rSO2) lasting 4 minutes or longer between the cannulated and non-cannulated limb	A drop of 15% or more in StO2 for ≥ 4 minutes between the cannulated and non-cannulated leg during the cannulation period	Duration of the surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Difference in tissue oxygenation index (TOI) compared to baseline	A TOI shift below 50% from baseline in the cannulated leg	Duration of the surgery
Identification of predictors of poor distal perfusion in the cannulated limb	Seven variables will be analyzed for correlation with elevated StO2 differentials to identify risk factors for distal limb ischemia after peripheral cannulation for CPB: Patient age, Patient sex, Previous artery disease, Type of surgery (coronary artery bypass graft vs valve surgery),Arterial cannula size, Duration of cannulation, Body Surface Area	from surgery until 6 months after surgery
Peripheral vascular surgery	Prevalence of peripheral vascular surgery within six months after cardiac surgery (telephonic follow-up after 6 months and revision of patients medical record)	6 months after surgery
Relationship between distal limb ischemia and acute kidney injury	Investigate a possible relationship between distal limb ischemia and acute kidney injury	through study completion, an average of 6 months

Collaborators and Investigators

• Sponsor: Jessa Hospital

Study record dates

Study Major Dates

• Study Start (Actual): November 25, 2019
• Primary Completion (Actual): January 27, 2021
• Study Completion (Actual): June 27, 2021

Study Registration Dates

• First Submitted: September 2, 2019
• First Submitted That Met QC Criteria: September 6, 2019
• First Posted (Actual): September 9, 2019

Study Record Updates

• Last Update Posted (Actual): June 7, 2022
• Last Update Submitted That Met QC Criteria: June 2, 2022
• Last Verified: June 1, 2022

More Information

Terms related to this study

• Keywords: Ischemia; Minimally invasive cardiac surgery; Distal limb perfusion
• Additional Relevant MeSH Terms: Pathologic Processes; Ischemia
• Other Study ID Numbers: Leg perfusion

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No